Data for ST001165   

(Analysis AN001926): Average values per metabolite and experimental factor (Units:Peak height)

Metabolite structureAll dataF1F2F3F4
1_CE (22:1) iSTD
324622.60 327893.67 323048.73 326297.60
1_Ceramide C17 iSTD
893408.33 841942.93 859416.60 865448.67
1_Cholesterol d7 iSTD
57797.40 54221.27 55103.67 54679.13
1_CUDA (pos) iSTD
348511.00 355178.40 364170.53 354804.67
1_DG (12:0/12:0/0:0) iSTD
144027.93 135600.13 135099.73 135142.40
1_DG (18:1/2:0/0:0) iSTD
294241.13 282343.73 281430.87 286761.40
1_iSTD iSTD SM (d18:1/17:0) iSTD
117585.73 113293.93 115479.33 119439.80
1_LPC (17:0) iSTD
30305.33 28282.13 29073.80 28782.67
1_LPE (17:1) iSTD
141394.07 133603.60 137887.87 136997.00
1_MG (17:0/0:0/0:0) iSTD
70124.13 68173.33 66366.73 69368.40
1_PC (25:0) iSTD
30762.53 29036.80 29949.40 29227.27
1_PE (17:0/17:0) iSTD
375309.33 346152.53 348318.67 362166.27
1_Sphingosine (d17:1) iSTD
58063.00 56113.40 56585.73 57742.73
1_TG (17:0/17:1/17:0) d5 iSTD
1021236.20 983383.13 943674.00 1001661.60
DG (38:5)
1136.60 1015.80 1034.47 894.13
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)
1689.47 1520.53 1431.07 4243.00
LPC (14:0)
1290.07 1412.87 1476.60 1830.07
LPC (15:0)
1680.07 1967.93 1993.47 2604.60
LPC (16:0)
21168.60 22436.87 25023.67 34175.07
LPC (16:1)
1102.93 1028.87 1153.93 1744.20
LPC (18:1)
3763.47 1994.40 2288.13 3090.27
LPC (18:2)
1351.33 1048.20 1139.00 1386.60
LPC (20:3)
3701.47 3888.53 4350.47 5950.47
LPC (20:4)
1554.73 1375.47 1934.93 2750.40
LPC (20:5)
7306.33 8059.13 8053.33 14344.93
LPC (22:6)
9228.73 9463.47 11360.13 23689.13
PC (28:0)
26271.20 43736.00 33768.80 62454.67
PC (30:0)
23656.33 34142.60 29800.20 47666.60
PC (30:1)
4533.53 7880.47 6020.07 11244.67
PC (31:0)
8336.20 11218.87 9817.40 13109.53
PC (31:1)
18614.47 27918.20 23130.73 33192.87
PC (34:2)
14658.13 18856.47 16605.53 23446.73
PC (34:3)
2662.07 3319.60 3492.67 5568.60
PC (34:4)
4071.47 7211.73 5446.80 10694.53
PC (35:3)
1111.40 1693.00 1456.07 1986.80
PC (35:4)
1832.73 2629.47 2578.67 3981.87
PC (36:3) B
1790.93 1895.47 1811.00 2478.07
PC 36:4;
19212.20 27886.00 23792.73 37757.53
PC (36:4) A
20197.07 29432.07 29073.67 37843.87
PC (36:5) A
5501.33 8698.27 6910.33 12109.67
PC (36:5) B
192012.07 276425.80 244229.47 424070.47
PC (36:6)
43443.53 68989.07 57040.93 101860.80
PC (37:4)
3215.80 4271.40 3690.60 5808.53
PC 37:5; PC(19:1/18:4);
76600.60 108099.53 88722.60 134572.80
PC (37:6)
28552.80 41808.40 39003.60 68529.27
PC (38:5) A
10891.27 13845.53 12270.93 19422.33
PC (38:5) B
8313.73 10980.73 9066.67 14685.13
PC (38:6) A
754925.13 975453.73 859808.07 1375508.53
PC (38:6) B
3238.53 4136.60 4364.87 6072.93
PC (38:6) C
19285.20 23050.73 19659.73 33213.20
PC (38:7)
9836.53 14569.33 11784.00 22346.73
PC (39:6)
25291.60 36913.13 30904.47 49700.60
PC 40:10;
111017.93 157075.67 128235.60 207880.07
PC (40:5) A
2731.33 3722.87 3460.87 4477.33
PC (40:6) A
20380.33 29891.47 24519.80 37985.47
PC (40:7)
44827.47 55932.47 48421.93 71180.80
PC (40:8)
17351.80 21930.53 19486.07 31037.27
PC 42:11; PC(20:5/22:6);
411905.20 531020.20 478666.80 864826.73
PC (p-34:0) or PC (o-34:1)
1559.93 1748.13 1905.07 1829.87
PC (p-36:4) or PC (o-36:5)
6427.80 8344.13 7023.33 9768.27
PC (p-38:5) or PC (o-38:6)
268296.47 345945.53 331271.80 529776.67
PC (p-42:3) or PC (o-42:4)
1622.67 1722.73 1424.67 1624.73
PE (34:2)
1340.53 1362.20 1538.13 1703.47
PE (38:6)
21800.87 19010.53 18156.27 26531.67
PE (p-36:2) or PE (o-36:3)
10267.40 12553.73 10617.07 16282.60
PE (p-36:4) or PE (o-36:5)
2345.40 2879.87 2275.40 3182.67
PE (p-38:4) or PE (o-38:5)
24033.53 33840.00 29799.07 40017.07
PE (p-38:5) or PE (o-38:6)
14673.80 17935.93 13851.47 21118.13
PE (p-40:5) or PE (o-40:6)
12569.20 13297.80 11166.53 12645.87
Plasmenyl-PC 36:4;
48357.13 62902.60 55964.80 85673.53
Plasmenyl-PC 37:5;
35149.00 46205.07 40097.93 65459.33
Plasmenyl-PC 38:6;
14188.73 16770.47 14020.20 21684.27
SM (d36:2)
2003.73 970.00 947.60 965.80
SM (d36:3)
12526.40 18892.93 16118.87 24640.73
SM (d38:2)
2168.60 694.60 714.60 719.20
TG (54:5) A
10160.93 7034.27 7582.27 6659.13

Factors:

F1ph treatment:High | DO treatment:High
F2ph treatment:High | DO treatment:Low
F3ph treatment:Low | DO treatment:High
F4ph treatment:Low | DO treatment:Low
  logo